Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
13 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/intensity-therapeutics-reports-first-quarter-2025-financial-results-and-provides-corporate-update-302454456.html
08 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/intensity-therapeutics-selected-for-oral-podium-presentation-in-a-late-breaking-session-at-the-2024-annual-connective-tissue-oncology-society-sarcomas-meeting-302296991.html
15 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/intensity-therapeutics-inc-announces-the-appointment-of-thomas-dubin-to-its-board-of-directors-302145873.html
03 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/intensity-therapeutics-provides-business-update-reflecting-progress-in-phase-3-sarcoma-program-302024890.html
12 Dec 2023
// PRESS RELEASE
https://ir.intensitytherapeutics.com/news-events/press-releases/detail/77/intensity-therapeutics-appoints-joseph-talamo-cpa-as
08 Dec 2023
// PRESS RELEASE
https://ir.intensitytherapeutics.com/news-events/press-releases/detail/76/intensity-therapeutics-presents-positive-int230-6-data-in
ABOUT THIS PAGE